St. Catherine Specialty Hospital in Zagreb, together with the International Center for Applied Biological Research, is positioning Croatia as a European leader in personalized medicine. Under the leadership of Dr. Dragan Primorac—recognized among the world’s top 2% of scientists—the hospital integrates whole genome sequencing (WGS) and AI-driven tools like OncoOrigin into routine clinical practice.
Their approach spans precision oncology, pharmacogenomics, nutrigenomics, and liquid biopsy, offering individualized care that improves outcomes and reduces costs. Partnerships with Dartmouth Health, UPMC, and academic institutions such as Penn State enable joint research, training, and the international validation of diagnostic methods.
St. Catherine’s pioneering use of WGS for early disease detection, personalized therapies, and real-time tumor monitoring is redefining care in fields like cardiology, oncology, and psychiatry. Initiatives such as genetic screening of athletes and proprietary nutrition software showcase the hospital’s preventive focus.
With over two decades of global collaboration—including co-hosting conferences with the Mayo Clinic and ISABS—St. Catherine is not only advancing translational genomics in Croatia, but also shaping the global future of personalized, AI-powered healthcare.
Read more in EU Reporter’s latest article, available on the link below.